Business

GlaxoSmithKline to pay Mass. over $35m

Accord part of $3b US fraud settlement

The pharmaceutical giant GlaxoSmithKline has agreed to pay more than $35 million to Massachusetts’ Medicaid program as part of a $3 billion settlement with federal and state authorities, the largest health care fraud payment in US history.

The massive settlement, disclosed Monday by the Department of Justice, includes a guilty plea to three criminal charges by London-based GlaxoSmithKline, which has its US headquarters in Philadelphia.

Your comment is subject to the rules of our Posting Policy

This comment may appear on your public profile. Public Profile FAQ